Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
if (Configure::read('debug')) {
trigger_error($message, E_USER_WARNING);
} else {
$response = object(Cake\Http\Response) {
'status' => (int) 200,
'contentType' => 'text/html',
'headers' => [
'Content-Type' => [
[maximum depth reached]
]
],
'file' => null,
'fileRange' => [],
'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
'cacheDirectives' => [],
'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68025a03beeb3-trace').style.display = (document.getElementById('cakeErr68025a03beeb3-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr68025a03beeb3-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68025a03beeb3-code').style.display = (document.getElementById('cakeErr68025a03beeb3-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr68025a03beeb3-context').style.display = (document.getElementById('cakeErr68025a03beeb3-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr68025a03beeb3-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">>
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/>
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/>
</span></span></code></pre><pre id="cakeErr68025a03beeb3-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
'article_current' => object(App\Model\Entity\Article) {
'id' => (int) 59777,
'title' => 'India’s vaccine policy needs clarity -K Sujatha Rao',
'subheading' => null,
'description' => '<p style="text-align:justify">-The Hindu</p>
<p style="text-align:justify"><em>In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement</em></p>
<p style="text-align:justify">Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding of history, and present conditions. Considering the vast sea of unknowns surrounding COVID-19, it would be understandable to place a greater reliance on historical experience. Instead, India&rsquo;s vaccine policy appears to be one of experimentation. Despite several modifications, the final policy as articulated by the Prime Minister on June 7 continues to lack clarity in its intent, design, funding and outcomes. In seeking to pursue conflicting objectives, the policy architecture is complex, difficult to implement, and could be a nightmare for accountants.</p>
<p style="text-align:justify"><em>The vaccine policy</em></p>
<p style="text-align:justify">After much loss of time, the final policy has the following elements: the stated objective is universal access to free vaccinations in all government and accredited facilities; the design for achieving the objective is creating a dual market under which the Central government will procure 75% of the total quantity manufactured, leaving the residue for commercial sale. The funding will be a mix of public finance and out-of-pocket expenditure. The outcome is to ensure that all 95 crore adults are fully vaccinated by the end of this year.</p>
<p style="text-align:justify">The policy has two caveats related to pricing and volume of sales. While Covishield and Covaxin are supplied to the Central government at ₹150 per dose, the price for a consumer in the private market is capped at ₹780 for Covishield, ₹1,145 for Sputnik V and ₹1,410 for Covaxin. To avoid cornering of vaccines by corporates and enable medium and small hospitals to participate in vaccination, the Central government will specify hospital-wise and State-wise quotas for private sales. Based on the quota allocated, the said hospitals will procure the vaccine directly from the manufacturer or use the option of the National Health Authority portal, if accredited.</p>
<p style="text-align:justify">Compare this maze with the policy followed under the Universal Immunisation Programme &ndash; the Central government indicates the quantity required, the delivery schedules and the rates as per global tender, and supplies quality, ready-to-use vaccines to the States to be provided free. The manufacturer is left to dispose of excess quantity, if any, in accordance with market forces and without interference from the government. Under this system, the government has negotiated incredibly low prices due to the volume of its orders. In view of its wide reach, the private sector&rsquo;s participation, catering to the better-off sections which have the ability to pay, has averaged 5%-15% depending on the vaccine.</p>
<p style="text-align:justify">Please <a href="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true">click here</a> to read more.&nbsp;</p>
',
'credit_writer' => 'The Hindu, 22 June, 2021, https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true',
'article_img' => '',
'article_img_thumb' => '',
'status' => (int) 1,
'show_on_home' => (int) 1,
'lang' => 'EN',
'category_id' => (int) 16,
'tag_keyword' => '',
'seo_url' => 'india-s-vaccine-policy-needs-clarity-k-sujatha-rao',
'meta_title' => '',
'meta_keywords' => '',
'meta_description' => '',
'noindex' => (int) 1,
'publish_date' => object(Cake\I18n\FrozenDate) {},
'most_visit_section_id' => null,
'article_big_img' => null,
'liveid' => null,
'created' => object(Cake\I18n\FrozenTime) {},
'modified' => object(Cake\I18n\FrozenTime) {},
'edate' => '',
'tags' => [
[maximum depth reached]
],
'category' => object(App\Model\Entity\Category) {},
'[new]' => false,
'[accessible]' => [
[maximum depth reached]
],
'[dirty]' => [[maximum depth reached]],
'[original]' => [[maximum depth reached]],
'[virtual]' => [[maximum depth reached]],
'[hasErrors]' => false,
'[errors]' => [[maximum depth reached]],
'[invalid]' => [[maximum depth reached]],
'[repository]' => 'Articles'
},
'articleid' => (int) 59777,
'metaTitle' => 'LATEST NEWS UPDATES | India’s vaccine policy needs clarity -K Sujatha Rao',
'metaKeywords' => 'Covaxin,Covishield,Public goods,Public procurement,Vaccination,Vaccine policy,Universal Immunisation Programme',
'metaDesc' => '-The Hindu
In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement
Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding...',
'disp' => '<p style="text-align:justify">-The Hindu</p><p style="text-align:justify"><em>In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement</em></p><p style="text-align:justify">Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding of history, and present conditions. Considering the vast sea of unknowns surrounding COVID-19, it would be understandable to place a greater reliance on historical experience. Instead, India&rsquo;s vaccine policy appears to be one of experimentation. Despite several modifications, the final policy as articulated by the Prime Minister on June 7 continues to lack clarity in its intent, design, funding and outcomes. In seeking to pursue conflicting objectives, the policy architecture is complex, difficult to implement, and could be a nightmare for accountants.</p><p style="text-align:justify"><em>The vaccine policy</em></p><p style="text-align:justify">After much loss of time, the final policy has the following elements: the stated objective is universal access to free vaccinations in all government and accredited facilities; the design for achieving the objective is creating a dual market under which the Central government will procure 75% of the total quantity manufactured, leaving the residue for commercial sale. The funding will be a mix of public finance and out-of-pocket expenditure. The outcome is to ensure that all 95 crore adults are fully vaccinated by the end of this year.</p><p style="text-align:justify">The policy has two caveats related to pricing and volume of sales. While Covishield and Covaxin are supplied to the Central government at 150 per dose, the price for a consumer in the private market is capped at 780 for Covishield, 1,145 for Sputnik V and 1,410 for Covaxin. To avoid cornering of vaccines by corporates and enable medium and small hospitals to participate in vaccination, the Central government will specify hospital-wise and State-wise quotas for private sales. Based on the quota allocated, the said hospitals will procure the vaccine directly from the manufacturer or use the option of the National Health Authority portal, if accredited.</p><p style="text-align:justify">Compare this maze with the policy followed under the Universal Immunisation Programme &ndash; the Central government indicates the quantity required, the delivery schedules and the rates as per global tender, and supplies quality, ready-to-use vaccines to the States to be provided free. The manufacturer is left to dispose of excess quantity, if any, in accordance with market forces and without interference from the government. Under this system, the government has negotiated incredibly low prices due to the volume of its orders. In view of its wide reach, the private sector&rsquo;s participation, catering to the better-off sections which have the ability to pay, has averaged 5%-15% depending on the vaccine.</p><p style="text-align:justify">Please <a href="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true" title="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true">click here</a> to read more.&nbsp;</p>',
'lang' => 'English',
'SITE_URL' => 'https://im4change.in/',
'site_title' => 'im4change',
'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {
'id' => (int) 59777,
'title' => 'India’s vaccine policy needs clarity -K Sujatha Rao',
'subheading' => null,
'description' => '<p style="text-align:justify">-The Hindu</p>
<p style="text-align:justify"><em>In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement</em></p>
<p style="text-align:justify">Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding of history, and present conditions. Considering the vast sea of unknowns surrounding COVID-19, it would be understandable to place a greater reliance on historical experience. Instead, India&rsquo;s vaccine policy appears to be one of experimentation. Despite several modifications, the final policy as articulated by the Prime Minister on June 7 continues to lack clarity in its intent, design, funding and outcomes. In seeking to pursue conflicting objectives, the policy architecture is complex, difficult to implement, and could be a nightmare for accountants.</p>
<p style="text-align:justify"><em>The vaccine policy</em></p>
<p style="text-align:justify">After much loss of time, the final policy has the following elements: the stated objective is universal access to free vaccinations in all government and accredited facilities; the design for achieving the objective is creating a dual market under which the Central government will procure 75% of the total quantity manufactured, leaving the residue for commercial sale. The funding will be a mix of public finance and out-of-pocket expenditure. The outcome is to ensure that all 95 crore adults are fully vaccinated by the end of this year.</p>
<p style="text-align:justify">The policy has two caveats related to pricing and volume of sales. While Covishield and Covaxin are supplied to the Central government at ₹150 per dose, the price for a consumer in the private market is capped at ₹780 for Covishield, ₹1,145 for Sputnik V and ₹1,410 for Covaxin. To avoid cornering of vaccines by corporates and enable medium and small hospitals to participate in vaccination, the Central government will specify hospital-wise and State-wise quotas for private sales. Based on the quota allocated, the said hospitals will procure the vaccine directly from the manufacturer or use the option of the National Health Authority portal, if accredited.</p>
<p style="text-align:justify">Compare this maze with the policy followed under the Universal Immunisation Programme &ndash; the Central government indicates the quantity required, the delivery schedules and the rates as per global tender, and supplies quality, ready-to-use vaccines to the States to be provided free. The manufacturer is left to dispose of excess quantity, if any, in accordance with market forces and without interference from the government. Under this system, the government has negotiated incredibly low prices due to the volume of its orders. In view of its wide reach, the private sector&rsquo;s participation, catering to the better-off sections which have the ability to pay, has averaged 5%-15% depending on the vaccine.</p>
<p style="text-align:justify">Please <a href="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true">click here</a> to read more.&nbsp;</p>
',
'credit_writer' => 'The Hindu, 22 June, 2021, https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true',
'article_img' => '',
'article_img_thumb' => '',
'status' => (int) 1,
'show_on_home' => (int) 1,
'lang' => 'EN',
'category_id' => (int) 16,
'tag_keyword' => '',
'seo_url' => 'india-s-vaccine-policy-needs-clarity-k-sujatha-rao',
'meta_title' => '',
'meta_keywords' => '',
'meta_description' => '',
'noindex' => (int) 1,
'publish_date' => object(Cake\I18n\FrozenDate) {},
'most_visit_section_id' => null,
'article_big_img' => null,
'liveid' => null,
'created' => object(Cake\I18n\FrozenTime) {},
'modified' => object(Cake\I18n\FrozenTime) {},
'edate' => '',
'tags' => [
(int) 0 => object(Cake\ORM\Entity) {},
(int) 1 => object(Cake\ORM\Entity) {},
(int) 2 => object(Cake\ORM\Entity) {},
(int) 3 => object(Cake\ORM\Entity) {},
(int) 4 => object(Cake\ORM\Entity) {},
(int) 5 => object(Cake\ORM\Entity) {},
(int) 6 => object(Cake\ORM\Entity) {}
],
'category' => object(App\Model\Entity\Category) {},
'[new]' => false,
'[accessible]' => [
'*' => true,
'id' => false
],
'[dirty]' => [],
'[original]' => [],
'[virtual]' => [],
'[hasErrors]' => false,
'[errors]' => [],
'[invalid]' => [],
'[repository]' => 'Articles'
}
$articleid = (int) 59777
$metaTitle = 'LATEST NEWS UPDATES | India’s vaccine policy needs clarity -K Sujatha Rao'
$metaKeywords = 'Covaxin,Covishield,Public goods,Public procurement,Vaccination,Vaccine policy,Universal Immunisation Programme'
$metaDesc = '-The Hindu
In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement
Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding...'
$disp = '<p style="text-align:justify">-The Hindu</p><p style="text-align:justify"><em>In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement</em></p><p style="text-align:justify">Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding of history, and present conditions. Considering the vast sea of unknowns surrounding COVID-19, it would be understandable to place a greater reliance on historical experience. Instead, India&rsquo;s vaccine policy appears to be one of experimentation. Despite several modifications, the final policy as articulated by the Prime Minister on June 7 continues to lack clarity in its intent, design, funding and outcomes. In seeking to pursue conflicting objectives, the policy architecture is complex, difficult to implement, and could be a nightmare for accountants.</p><p style="text-align:justify"><em>The vaccine policy</em></p><p style="text-align:justify">After much loss of time, the final policy has the following elements: the stated objective is universal access to free vaccinations in all government and accredited facilities; the design for achieving the objective is creating a dual market under which the Central government will procure 75% of the total quantity manufactured, leaving the residue for commercial sale. The funding will be a mix of public finance and out-of-pocket expenditure. The outcome is to ensure that all 95 crore adults are fully vaccinated by the end of this year.</p><p style="text-align:justify">The policy has two caveats related to pricing and volume of sales. While Covishield and Covaxin are supplied to the Central government at 150 per dose, the price for a consumer in the private market is capped at 780 for Covishield, 1,145 for Sputnik V and 1,410 for Covaxin. To avoid cornering of vaccines by corporates and enable medium and small hospitals to participate in vaccination, the Central government will specify hospital-wise and State-wise quotas for private sales. Based on the quota allocated, the said hospitals will procure the vaccine directly from the manufacturer or use the option of the National Health Authority portal, if accredited.</p><p style="text-align:justify">Compare this maze with the policy followed under the Universal Immunisation Programme &ndash; the Central government indicates the quantity required, the delivery schedules and the rates as per global tender, and supplies quality, ready-to-use vaccines to the States to be provided free. The manufacturer is left to dispose of excess quantity, if any, in accordance with market forces and without interference from the government. Under this system, the government has negotiated incredibly low prices due to the volume of its orders. In view of its wide reach, the private sector&rsquo;s participation, catering to the better-off sections which have the ability to pay, has averaged 5%-15% depending on the vaccine.</p><p style="text-align:justify">Please <a href="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true" title="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true">click here</a> to read more.&nbsp;</p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/india-s-vaccine-policy-needs-clarity-k-sujatha-rao.html"/>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
<link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
media="all"/>
<title>LATEST NEWS UPDATES | India’s vaccine policy needs clarity -K Sujatha Rao | Im4change.org</title>
<meta name="description" content="-The Hindu
In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement
Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding..."/>
<script src="https://im4change.in/js/jquery-1.10.2.js"></script>
<script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
<script language="javascript" type="text/javascript">
$(document).ready(function () {
var img = $("img")[0]; // Get my img elem
var pic_real_width, pic_real_height;
$("<img/>") // Make in memory copy of image to avoid css issues
.attr("src", $(img).attr("src"))
.load(function () {
pic_real_width = this.width; // Note: $(this).width() will not
pic_real_height = this.height; // work for in memory images.
});
});
</script>
<style type="text/css">
@media screen {
div.divFooter {
display: block;
}
}
@media print {
.printbutton {
display: none !important;
}
}
</style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
<tr>
<td class="top_bg">
<div class="divFooter">
<img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
</div>
</td>
</tr>
<tr>
<td id="topspace"> </td>
</tr>
<tr id="topspace">
<td> </td>
</tr>
<tr>
<td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
<form><input type="button" value=" Print this page "
onclick="window.print();return false;"/></form>
</td>
</tr>
<tr>
<td width="100%">
<h1 class="news_headlines" style="font-style:normal">
<strong>India’s vaccine policy needs clarity -K Sujatha Rao</strong></h1>
</td>
</tr>
<tr>
<td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
<p style="text-align:justify">-The Hindu</p><p style="text-align:justify"><em>In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement</em></p><p style="text-align:justify">Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding of history, and present conditions. Considering the vast sea of unknowns surrounding COVID-19, it would be understandable to place a greater reliance on historical experience. Instead, India’s vaccine policy appears to be one of experimentation. Despite several modifications, the final policy as articulated by the Prime Minister on June 7 continues to lack clarity in its intent, design, funding and outcomes. In seeking to pursue conflicting objectives, the policy architecture is complex, difficult to implement, and could be a nightmare for accountants.</p><p style="text-align:justify"><em>The vaccine policy</em></p><p style="text-align:justify">After much loss of time, the final policy has the following elements: the stated objective is universal access to free vaccinations in all government and accredited facilities; the design for achieving the objective is creating a dual market under which the Central government will procure 75% of the total quantity manufactured, leaving the residue for commercial sale. The funding will be a mix of public finance and out-of-pocket expenditure. The outcome is to ensure that all 95 crore adults are fully vaccinated by the end of this year.</p><p style="text-align:justify">The policy has two caveats related to pricing and volume of sales. While Covishield and Covaxin are supplied to the Central government at 150 per dose, the price for a consumer in the private market is capped at 780 for Covishield, 1,145 for Sputnik V and 1,410 for Covaxin. To avoid cornering of vaccines by corporates and enable medium and small hospitals to participate in vaccination, the Central government will specify hospital-wise and State-wise quotas for private sales. Based on the quota allocated, the said hospitals will procure the vaccine directly from the manufacturer or use the option of the National Health Authority portal, if accredited.</p><p style="text-align:justify">Compare this maze with the policy followed under the Universal Immunisation Programme – the Central government indicates the quantity required, the delivery schedules and the rates as per global tender, and supplies quality, ready-to-use vaccines to the States to be provided free. The manufacturer is left to dispose of excess quantity, if any, in accordance with market forces and without interference from the government. Under this system, the government has negotiated incredibly low prices due to the volume of its orders. In view of its wide reach, the private sector’s participation, catering to the better-off sections which have the ability to pay, has averaged 5%-15% depending on the vaccine.</p><p style="text-align:justify">Please <a href="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true" title="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true">click here</a> to read more. </p> </font>
</td>
</tr>
<tr>
<td> </td>
</tr>
<tr>
<td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
<form><input type="button" value=" Print this page "
onclick="window.print();return false;"/></form>
</td>
</tr>
</table></body>
</html>'
}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
$response = object(Cake\Http\Response) {
'status' => (int) 200,
'contentType' => 'text/html',
'headers' => [
'Content-Type' => [
[maximum depth reached]
]
],
'file' => null,
'fileRange' => [],
'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
'cacheDirectives' => [],
'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68025a03beeb3-trace').style.display = (document.getElementById('cakeErr68025a03beeb3-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr68025a03beeb3-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68025a03beeb3-code').style.display = (document.getElementById('cakeErr68025a03beeb3-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr68025a03beeb3-context').style.display = (document.getElementById('cakeErr68025a03beeb3-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr68025a03beeb3-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">>
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/>
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/>
</span></span></code></pre><pre id="cakeErr68025a03beeb3-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
'article_current' => object(App\Model\Entity\Article) {
'id' => (int) 59777,
'title' => 'India’s vaccine policy needs clarity -K Sujatha Rao',
'subheading' => null,
'description' => '<p style="text-align:justify">-The Hindu</p>
<p style="text-align:justify"><em>In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement</em></p>
<p style="text-align:justify">Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding of history, and present conditions. Considering the vast sea of unknowns surrounding COVID-19, it would be understandable to place a greater reliance on historical experience. Instead, India&rsquo;s vaccine policy appears to be one of experimentation. Despite several modifications, the final policy as articulated by the Prime Minister on June 7 continues to lack clarity in its intent, design, funding and outcomes. In seeking to pursue conflicting objectives, the policy architecture is complex, difficult to implement, and could be a nightmare for accountants.</p>
<p style="text-align:justify"><em>The vaccine policy</em></p>
<p style="text-align:justify">After much loss of time, the final policy has the following elements: the stated objective is universal access to free vaccinations in all government and accredited facilities; the design for achieving the objective is creating a dual market under which the Central government will procure 75% of the total quantity manufactured, leaving the residue for commercial sale. The funding will be a mix of public finance and out-of-pocket expenditure. The outcome is to ensure that all 95 crore adults are fully vaccinated by the end of this year.</p>
<p style="text-align:justify">The policy has two caveats related to pricing and volume of sales. While Covishield and Covaxin are supplied to the Central government at ₹150 per dose, the price for a consumer in the private market is capped at ₹780 for Covishield, ₹1,145 for Sputnik V and ₹1,410 for Covaxin. To avoid cornering of vaccines by corporates and enable medium and small hospitals to participate in vaccination, the Central government will specify hospital-wise and State-wise quotas for private sales. Based on the quota allocated, the said hospitals will procure the vaccine directly from the manufacturer or use the option of the National Health Authority portal, if accredited.</p>
<p style="text-align:justify">Compare this maze with the policy followed under the Universal Immunisation Programme &ndash; the Central government indicates the quantity required, the delivery schedules and the rates as per global tender, and supplies quality, ready-to-use vaccines to the States to be provided free. The manufacturer is left to dispose of excess quantity, if any, in accordance with market forces and without interference from the government. Under this system, the government has negotiated incredibly low prices due to the volume of its orders. In view of its wide reach, the private sector&rsquo;s participation, catering to the better-off sections which have the ability to pay, has averaged 5%-15% depending on the vaccine.</p>
<p style="text-align:justify">Please <a href="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true">click here</a> to read more.&nbsp;</p>
',
'credit_writer' => 'The Hindu, 22 June, 2021, https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true',
'article_img' => '',
'article_img_thumb' => '',
'status' => (int) 1,
'show_on_home' => (int) 1,
'lang' => 'EN',
'category_id' => (int) 16,
'tag_keyword' => '',
'seo_url' => 'india-s-vaccine-policy-needs-clarity-k-sujatha-rao',
'meta_title' => '',
'meta_keywords' => '',
'meta_description' => '',
'noindex' => (int) 1,
'publish_date' => object(Cake\I18n\FrozenDate) {},
'most_visit_section_id' => null,
'article_big_img' => null,
'liveid' => null,
'created' => object(Cake\I18n\FrozenTime) {},
'modified' => object(Cake\I18n\FrozenTime) {},
'edate' => '',
'tags' => [
[maximum depth reached]
],
'category' => object(App\Model\Entity\Category) {},
'[new]' => false,
'[accessible]' => [
[maximum depth reached]
],
'[dirty]' => [[maximum depth reached]],
'[original]' => [[maximum depth reached]],
'[virtual]' => [[maximum depth reached]],
'[hasErrors]' => false,
'[errors]' => [[maximum depth reached]],
'[invalid]' => [[maximum depth reached]],
'[repository]' => 'Articles'
},
'articleid' => (int) 59777,
'metaTitle' => 'LATEST NEWS UPDATES | India’s vaccine policy needs clarity -K Sujatha Rao',
'metaKeywords' => 'Covaxin,Covishield,Public goods,Public procurement,Vaccination,Vaccine policy,Universal Immunisation Programme',
'metaDesc' => '-The Hindu
In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement
Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding...',
'disp' => '<p style="text-align:justify">-The Hindu</p><p style="text-align:justify"><em>In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement</em></p><p style="text-align:justify">Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding of history, and present conditions. Considering the vast sea of unknowns surrounding COVID-19, it would be understandable to place a greater reliance on historical experience. Instead, India&rsquo;s vaccine policy appears to be one of experimentation. Despite several modifications, the final policy as articulated by the Prime Minister on June 7 continues to lack clarity in its intent, design, funding and outcomes. In seeking to pursue conflicting objectives, the policy architecture is complex, difficult to implement, and could be a nightmare for accountants.</p><p style="text-align:justify"><em>The vaccine policy</em></p><p style="text-align:justify">After much loss of time, the final policy has the following elements: the stated objective is universal access to free vaccinations in all government and accredited facilities; the design for achieving the objective is creating a dual market under which the Central government will procure 75% of the total quantity manufactured, leaving the residue for commercial sale. The funding will be a mix of public finance and out-of-pocket expenditure. The outcome is to ensure that all 95 crore adults are fully vaccinated by the end of this year.</p><p style="text-align:justify">The policy has two caveats related to pricing and volume of sales. While Covishield and Covaxin are supplied to the Central government at 150 per dose, the price for a consumer in the private market is capped at 780 for Covishield, 1,145 for Sputnik V and 1,410 for Covaxin. To avoid cornering of vaccines by corporates and enable medium and small hospitals to participate in vaccination, the Central government will specify hospital-wise and State-wise quotas for private sales. Based on the quota allocated, the said hospitals will procure the vaccine directly from the manufacturer or use the option of the National Health Authority portal, if accredited.</p><p style="text-align:justify">Compare this maze with the policy followed under the Universal Immunisation Programme &ndash; the Central government indicates the quantity required, the delivery schedules and the rates as per global tender, and supplies quality, ready-to-use vaccines to the States to be provided free. The manufacturer is left to dispose of excess quantity, if any, in accordance with market forces and without interference from the government. Under this system, the government has negotiated incredibly low prices due to the volume of its orders. In view of its wide reach, the private sector&rsquo;s participation, catering to the better-off sections which have the ability to pay, has averaged 5%-15% depending on the vaccine.</p><p style="text-align:justify">Please <a href="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true" title="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true">click here</a> to read more.&nbsp;</p>',
'lang' => 'English',
'SITE_URL' => 'https://im4change.in/',
'site_title' => 'im4change',
'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {
'id' => (int) 59777,
'title' => 'India’s vaccine policy needs clarity -K Sujatha Rao',
'subheading' => null,
'description' => '<p style="text-align:justify">-The Hindu</p>
<p style="text-align:justify"><em>In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement</em></p>
<p style="text-align:justify">Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding of history, and present conditions. Considering the vast sea of unknowns surrounding COVID-19, it would be understandable to place a greater reliance on historical experience. Instead, India&rsquo;s vaccine policy appears to be one of experimentation. Despite several modifications, the final policy as articulated by the Prime Minister on June 7 continues to lack clarity in its intent, design, funding and outcomes. In seeking to pursue conflicting objectives, the policy architecture is complex, difficult to implement, and could be a nightmare for accountants.</p>
<p style="text-align:justify"><em>The vaccine policy</em></p>
<p style="text-align:justify">After much loss of time, the final policy has the following elements: the stated objective is universal access to free vaccinations in all government and accredited facilities; the design for achieving the objective is creating a dual market under which the Central government will procure 75% of the total quantity manufactured, leaving the residue for commercial sale. The funding will be a mix of public finance and out-of-pocket expenditure. The outcome is to ensure that all 95 crore adults are fully vaccinated by the end of this year.</p>
<p style="text-align:justify">The policy has two caveats related to pricing and volume of sales. While Covishield and Covaxin are supplied to the Central government at ₹150 per dose, the price for a consumer in the private market is capped at ₹780 for Covishield, ₹1,145 for Sputnik V and ₹1,410 for Covaxin. To avoid cornering of vaccines by corporates and enable medium and small hospitals to participate in vaccination, the Central government will specify hospital-wise and State-wise quotas for private sales. Based on the quota allocated, the said hospitals will procure the vaccine directly from the manufacturer or use the option of the National Health Authority portal, if accredited.</p>
<p style="text-align:justify">Compare this maze with the policy followed under the Universal Immunisation Programme &ndash; the Central government indicates the quantity required, the delivery schedules and the rates as per global tender, and supplies quality, ready-to-use vaccines to the States to be provided free. The manufacturer is left to dispose of excess quantity, if any, in accordance with market forces and without interference from the government. Under this system, the government has negotiated incredibly low prices due to the volume of its orders. In view of its wide reach, the private sector&rsquo;s participation, catering to the better-off sections which have the ability to pay, has averaged 5%-15% depending on the vaccine.</p>
<p style="text-align:justify">Please <a href="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true">click here</a> to read more.&nbsp;</p>
',
'credit_writer' => 'The Hindu, 22 June, 2021, https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true',
'article_img' => '',
'article_img_thumb' => '',
'status' => (int) 1,
'show_on_home' => (int) 1,
'lang' => 'EN',
'category_id' => (int) 16,
'tag_keyword' => '',
'seo_url' => 'india-s-vaccine-policy-needs-clarity-k-sujatha-rao',
'meta_title' => '',
'meta_keywords' => '',
'meta_description' => '',
'noindex' => (int) 1,
'publish_date' => object(Cake\I18n\FrozenDate) {},
'most_visit_section_id' => null,
'article_big_img' => null,
'liveid' => null,
'created' => object(Cake\I18n\FrozenTime) {},
'modified' => object(Cake\I18n\FrozenTime) {},
'edate' => '',
'tags' => [
(int) 0 => object(Cake\ORM\Entity) {},
(int) 1 => object(Cake\ORM\Entity) {},
(int) 2 => object(Cake\ORM\Entity) {},
(int) 3 => object(Cake\ORM\Entity) {},
(int) 4 => object(Cake\ORM\Entity) {},
(int) 5 => object(Cake\ORM\Entity) {},
(int) 6 => object(Cake\ORM\Entity) {}
],
'category' => object(App\Model\Entity\Category) {},
'[new]' => false,
'[accessible]' => [
'*' => true,
'id' => false
],
'[dirty]' => [],
'[original]' => [],
'[virtual]' => [],
'[hasErrors]' => false,
'[errors]' => [],
'[invalid]' => [],
'[repository]' => 'Articles'
}
$articleid = (int) 59777
$metaTitle = 'LATEST NEWS UPDATES | India’s vaccine policy needs clarity -K Sujatha Rao'
$metaKeywords = 'Covaxin,Covishield,Public goods,Public procurement,Vaccination,Vaccine policy,Universal Immunisation Programme'
$metaDesc = '-The Hindu
In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement
Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding...'
$disp = '<p style="text-align:justify">-The Hindu</p><p style="text-align:justify"><em>In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement</em></p><p style="text-align:justify">Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding of history, and present conditions. Considering the vast sea of unknowns surrounding COVID-19, it would be understandable to place a greater reliance on historical experience. Instead, India&rsquo;s vaccine policy appears to be one of experimentation. Despite several modifications, the final policy as articulated by the Prime Minister on June 7 continues to lack clarity in its intent, design, funding and outcomes. In seeking to pursue conflicting objectives, the policy architecture is complex, difficult to implement, and could be a nightmare for accountants.</p><p style="text-align:justify"><em>The vaccine policy</em></p><p style="text-align:justify">After much loss of time, the final policy has the following elements: the stated objective is universal access to free vaccinations in all government and accredited facilities; the design for achieving the objective is creating a dual market under which the Central government will procure 75% of the total quantity manufactured, leaving the residue for commercial sale. The funding will be a mix of public finance and out-of-pocket expenditure. The outcome is to ensure that all 95 crore adults are fully vaccinated by the end of this year.</p><p style="text-align:justify">The policy has two caveats related to pricing and volume of sales. While Covishield and Covaxin are supplied to the Central government at 150 per dose, the price for a consumer in the private market is capped at 780 for Covishield, 1,145 for Sputnik V and 1,410 for Covaxin. To avoid cornering of vaccines by corporates and enable medium and small hospitals to participate in vaccination, the Central government will specify hospital-wise and State-wise quotas for private sales. Based on the quota allocated, the said hospitals will procure the vaccine directly from the manufacturer or use the option of the National Health Authority portal, if accredited.</p><p style="text-align:justify">Compare this maze with the policy followed under the Universal Immunisation Programme &ndash; the Central government indicates the quantity required, the delivery schedules and the rates as per global tender, and supplies quality, ready-to-use vaccines to the States to be provided free. The manufacturer is left to dispose of excess quantity, if any, in accordance with market forces and without interference from the government. Under this system, the government has negotiated incredibly low prices due to the volume of its orders. In view of its wide reach, the private sector&rsquo;s participation, catering to the better-off sections which have the ability to pay, has averaged 5%-15% depending on the vaccine.</p><p style="text-align:justify">Please <a href="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true" title="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true">click here</a> to read more.&nbsp;</p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/india-s-vaccine-policy-needs-clarity-k-sujatha-rao.html"/>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
<link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
media="all"/>
<title>LATEST NEWS UPDATES | India’s vaccine policy needs clarity -K Sujatha Rao | Im4change.org</title>
<meta name="description" content="-The Hindu
In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement
Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding..."/>
<script src="https://im4change.in/js/jquery-1.10.2.js"></script>
<script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
<script language="javascript" type="text/javascript">
$(document).ready(function () {
var img = $("img")[0]; // Get my img elem
var pic_real_width, pic_real_height;
$("<img/>") // Make in memory copy of image to avoid css issues
.attr("src", $(img).attr("src"))
.load(function () {
pic_real_width = this.width; // Note: $(this).width() will not
pic_real_height = this.height; // work for in memory images.
});
});
</script>
<style type="text/css">
@media screen {
div.divFooter {
display: block;
}
}
@media print {
.printbutton {
display: none !important;
}
}
</style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
<tr>
<td class="top_bg">
<div class="divFooter">
<img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
</div>
</td>
</tr>
<tr>
<td id="topspace"> </td>
</tr>
<tr id="topspace">
<td> </td>
</tr>
<tr>
<td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
<form><input type="button" value=" Print this page "
onclick="window.print();return false;"/></form>
</td>
</tr>
<tr>
<td width="100%">
<h1 class="news_headlines" style="font-style:normal">
<strong>India’s vaccine policy needs clarity -K Sujatha Rao</strong></h1>
</td>
</tr>
<tr>
<td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
<p style="text-align:justify">-The Hindu</p><p style="text-align:justify"><em>In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement</em></p><p style="text-align:justify">Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding of history, and present conditions. Considering the vast sea of unknowns surrounding COVID-19, it would be understandable to place a greater reliance on historical experience. Instead, India’s vaccine policy appears to be one of experimentation. Despite several modifications, the final policy as articulated by the Prime Minister on June 7 continues to lack clarity in its intent, design, funding and outcomes. In seeking to pursue conflicting objectives, the policy architecture is complex, difficult to implement, and could be a nightmare for accountants.</p><p style="text-align:justify"><em>The vaccine policy</em></p><p style="text-align:justify">After much loss of time, the final policy has the following elements: the stated objective is universal access to free vaccinations in all government and accredited facilities; the design for achieving the objective is creating a dual market under which the Central government will procure 75% of the total quantity manufactured, leaving the residue for commercial sale. The funding will be a mix of public finance and out-of-pocket expenditure. The outcome is to ensure that all 95 crore adults are fully vaccinated by the end of this year.</p><p style="text-align:justify">The policy has two caveats related to pricing and volume of sales. While Covishield and Covaxin are supplied to the Central government at 150 per dose, the price for a consumer in the private market is capped at 780 for Covishield, 1,145 for Sputnik V and 1,410 for Covaxin. To avoid cornering of vaccines by corporates and enable medium and small hospitals to participate in vaccination, the Central government will specify hospital-wise and State-wise quotas for private sales. Based on the quota allocated, the said hospitals will procure the vaccine directly from the manufacturer or use the option of the National Health Authority portal, if accredited.</p><p style="text-align:justify">Compare this maze with the policy followed under the Universal Immunisation Programme – the Central government indicates the quantity required, the delivery schedules and the rates as per global tender, and supplies quality, ready-to-use vaccines to the States to be provided free. The manufacturer is left to dispose of excess quantity, if any, in accordance with market forces and without interference from the government. Under this system, the government has negotiated incredibly low prices due to the volume of its orders. In view of its wide reach, the private sector’s participation, catering to the better-off sections which have the ability to pay, has averaged 5%-15% depending on the vaccine.</p><p style="text-align:justify">Please <a href="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true" title="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true">click here</a> to read more. </p> </font>
</td>
</tr>
<tr>
<td> </td>
</tr>
<tr>
<td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
<form><input type="button" value=" Print this page "
onclick="window.print();return false;"/></form>
</td>
</tr>
</table></body>
</html>'
}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
$response = object(Cake\Http\Response) {
'status' => (int) 200,
'contentType' => 'text/html',
'headers' => [
'Content-Type' => [
[maximum depth reached]
]
],
'file' => null,
'fileRange' => [],
'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
'cacheDirectives' => [],
'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68025a03beeb3-trace').style.display = (document.getElementById('cakeErr68025a03beeb3-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr68025a03beeb3-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68025a03beeb3-code').style.display = (document.getElementById('cakeErr68025a03beeb3-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr68025a03beeb3-context').style.display = (document.getElementById('cakeErr68025a03beeb3-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr68025a03beeb3-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">>
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/>
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/>
</span></span></code></pre><pre id="cakeErr68025a03beeb3-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
'article_current' => object(App\Model\Entity\Article) {
'id' => (int) 59777,
'title' => 'India’s vaccine policy needs clarity -K Sujatha Rao',
'subheading' => null,
'description' => '<p style="text-align:justify">-The Hindu</p>
<p style="text-align:justify"><em>In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement</em></p>
<p style="text-align:justify">Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding of history, and present conditions. Considering the vast sea of unknowns surrounding COVID-19, it would be understandable to place a greater reliance on historical experience. Instead, India&rsquo;s vaccine policy appears to be one of experimentation. Despite several modifications, the final policy as articulated by the Prime Minister on June 7 continues to lack clarity in its intent, design, funding and outcomes. In seeking to pursue conflicting objectives, the policy architecture is complex, difficult to implement, and could be a nightmare for accountants.</p>
<p style="text-align:justify"><em>The vaccine policy</em></p>
<p style="text-align:justify">After much loss of time, the final policy has the following elements: the stated objective is universal access to free vaccinations in all government and accredited facilities; the design for achieving the objective is creating a dual market under which the Central government will procure 75% of the total quantity manufactured, leaving the residue for commercial sale. The funding will be a mix of public finance and out-of-pocket expenditure. The outcome is to ensure that all 95 crore adults are fully vaccinated by the end of this year.</p>
<p style="text-align:justify">The policy has two caveats related to pricing and volume of sales. While Covishield and Covaxin are supplied to the Central government at ₹150 per dose, the price for a consumer in the private market is capped at ₹780 for Covishield, ₹1,145 for Sputnik V and ₹1,410 for Covaxin. To avoid cornering of vaccines by corporates and enable medium and small hospitals to participate in vaccination, the Central government will specify hospital-wise and State-wise quotas for private sales. Based on the quota allocated, the said hospitals will procure the vaccine directly from the manufacturer or use the option of the National Health Authority portal, if accredited.</p>
<p style="text-align:justify">Compare this maze with the policy followed under the Universal Immunisation Programme &ndash; the Central government indicates the quantity required, the delivery schedules and the rates as per global tender, and supplies quality, ready-to-use vaccines to the States to be provided free. The manufacturer is left to dispose of excess quantity, if any, in accordance with market forces and without interference from the government. Under this system, the government has negotiated incredibly low prices due to the volume of its orders. In view of its wide reach, the private sector&rsquo;s participation, catering to the better-off sections which have the ability to pay, has averaged 5%-15% depending on the vaccine.</p>
<p style="text-align:justify">Please <a href="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true">click here</a> to read more.&nbsp;</p>
',
'credit_writer' => 'The Hindu, 22 June, 2021, https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true',
'article_img' => '',
'article_img_thumb' => '',
'status' => (int) 1,
'show_on_home' => (int) 1,
'lang' => 'EN',
'category_id' => (int) 16,
'tag_keyword' => '',
'seo_url' => 'india-s-vaccine-policy-needs-clarity-k-sujatha-rao',
'meta_title' => '',
'meta_keywords' => '',
'meta_description' => '',
'noindex' => (int) 1,
'publish_date' => object(Cake\I18n\FrozenDate) {},
'most_visit_section_id' => null,
'article_big_img' => null,
'liveid' => null,
'created' => object(Cake\I18n\FrozenTime) {},
'modified' => object(Cake\I18n\FrozenTime) {},
'edate' => '',
'tags' => [
[maximum depth reached]
],
'category' => object(App\Model\Entity\Category) {},
'[new]' => false,
'[accessible]' => [
[maximum depth reached]
],
'[dirty]' => [[maximum depth reached]],
'[original]' => [[maximum depth reached]],
'[virtual]' => [[maximum depth reached]],
'[hasErrors]' => false,
'[errors]' => [[maximum depth reached]],
'[invalid]' => [[maximum depth reached]],
'[repository]' => 'Articles'
},
'articleid' => (int) 59777,
'metaTitle' => 'LATEST NEWS UPDATES | India’s vaccine policy needs clarity -K Sujatha Rao',
'metaKeywords' => 'Covaxin,Covishield,Public goods,Public procurement,Vaccination,Vaccine policy,Universal Immunisation Programme',
'metaDesc' => '-The Hindu
In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement
Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding...',
'disp' => '<p style="text-align:justify">-The Hindu</p><p style="text-align:justify"><em>In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement</em></p><p style="text-align:justify">Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding of history, and present conditions. Considering the vast sea of unknowns surrounding COVID-19, it would be understandable to place a greater reliance on historical experience. Instead, India&rsquo;s vaccine policy appears to be one of experimentation. Despite several modifications, the final policy as articulated by the Prime Minister on June 7 continues to lack clarity in its intent, design, funding and outcomes. In seeking to pursue conflicting objectives, the policy architecture is complex, difficult to implement, and could be a nightmare for accountants.</p><p style="text-align:justify"><em>The vaccine policy</em></p><p style="text-align:justify">After much loss of time, the final policy has the following elements: the stated objective is universal access to free vaccinations in all government and accredited facilities; the design for achieving the objective is creating a dual market under which the Central government will procure 75% of the total quantity manufactured, leaving the residue for commercial sale. The funding will be a mix of public finance and out-of-pocket expenditure. The outcome is to ensure that all 95 crore adults are fully vaccinated by the end of this year.</p><p style="text-align:justify">The policy has two caveats related to pricing and volume of sales. While Covishield and Covaxin are supplied to the Central government at 150 per dose, the price for a consumer in the private market is capped at 780 for Covishield, 1,145 for Sputnik V and 1,410 for Covaxin. To avoid cornering of vaccines by corporates and enable medium and small hospitals to participate in vaccination, the Central government will specify hospital-wise and State-wise quotas for private sales. Based on the quota allocated, the said hospitals will procure the vaccine directly from the manufacturer or use the option of the National Health Authority portal, if accredited.</p><p style="text-align:justify">Compare this maze with the policy followed under the Universal Immunisation Programme &ndash; the Central government indicates the quantity required, the delivery schedules and the rates as per global tender, and supplies quality, ready-to-use vaccines to the States to be provided free. The manufacturer is left to dispose of excess quantity, if any, in accordance with market forces and without interference from the government. Under this system, the government has negotiated incredibly low prices due to the volume of its orders. In view of its wide reach, the private sector&rsquo;s participation, catering to the better-off sections which have the ability to pay, has averaged 5%-15% depending on the vaccine.</p><p style="text-align:justify">Please <a href="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true" title="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true">click here</a> to read more.&nbsp;</p>',
'lang' => 'English',
'SITE_URL' => 'https://im4change.in/',
'site_title' => 'im4change',
'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {
'id' => (int) 59777,
'title' => 'India’s vaccine policy needs clarity -K Sujatha Rao',
'subheading' => null,
'description' => '<p style="text-align:justify">-The Hindu</p>
<p style="text-align:justify"><em>In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement</em></p>
<p style="text-align:justify">Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding of history, and present conditions. Considering the vast sea of unknowns surrounding COVID-19, it would be understandable to place a greater reliance on historical experience. Instead, India&rsquo;s vaccine policy appears to be one of experimentation. Despite several modifications, the final policy as articulated by the Prime Minister on June 7 continues to lack clarity in its intent, design, funding and outcomes. In seeking to pursue conflicting objectives, the policy architecture is complex, difficult to implement, and could be a nightmare for accountants.</p>
<p style="text-align:justify"><em>The vaccine policy</em></p>
<p style="text-align:justify">After much loss of time, the final policy has the following elements: the stated objective is universal access to free vaccinations in all government and accredited facilities; the design for achieving the objective is creating a dual market under which the Central government will procure 75% of the total quantity manufactured, leaving the residue for commercial sale. The funding will be a mix of public finance and out-of-pocket expenditure. The outcome is to ensure that all 95 crore adults are fully vaccinated by the end of this year.</p>
<p style="text-align:justify">The policy has two caveats related to pricing and volume of sales. While Covishield and Covaxin are supplied to the Central government at ₹150 per dose, the price for a consumer in the private market is capped at ₹780 for Covishield, ₹1,145 for Sputnik V and ₹1,410 for Covaxin. To avoid cornering of vaccines by corporates and enable medium and small hospitals to participate in vaccination, the Central government will specify hospital-wise and State-wise quotas for private sales. Based on the quota allocated, the said hospitals will procure the vaccine directly from the manufacturer or use the option of the National Health Authority portal, if accredited.</p>
<p style="text-align:justify">Compare this maze with the policy followed under the Universal Immunisation Programme &ndash; the Central government indicates the quantity required, the delivery schedules and the rates as per global tender, and supplies quality, ready-to-use vaccines to the States to be provided free. The manufacturer is left to dispose of excess quantity, if any, in accordance with market forces and without interference from the government. Under this system, the government has negotiated incredibly low prices due to the volume of its orders. In view of its wide reach, the private sector&rsquo;s participation, catering to the better-off sections which have the ability to pay, has averaged 5%-15% depending on the vaccine.</p>
<p style="text-align:justify">Please <a href="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true">click here</a> to read more.&nbsp;</p>
',
'credit_writer' => 'The Hindu, 22 June, 2021, https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true',
'article_img' => '',
'article_img_thumb' => '',
'status' => (int) 1,
'show_on_home' => (int) 1,
'lang' => 'EN',
'category_id' => (int) 16,
'tag_keyword' => '',
'seo_url' => 'india-s-vaccine-policy-needs-clarity-k-sujatha-rao',
'meta_title' => '',
'meta_keywords' => '',
'meta_description' => '',
'noindex' => (int) 1,
'publish_date' => object(Cake\I18n\FrozenDate) {},
'most_visit_section_id' => null,
'article_big_img' => null,
'liveid' => null,
'created' => object(Cake\I18n\FrozenTime) {},
'modified' => object(Cake\I18n\FrozenTime) {},
'edate' => '',
'tags' => [
(int) 0 => object(Cake\ORM\Entity) {},
(int) 1 => object(Cake\ORM\Entity) {},
(int) 2 => object(Cake\ORM\Entity) {},
(int) 3 => object(Cake\ORM\Entity) {},
(int) 4 => object(Cake\ORM\Entity) {},
(int) 5 => object(Cake\ORM\Entity) {},
(int) 6 => object(Cake\ORM\Entity) {}
],
'category' => object(App\Model\Entity\Category) {},
'[new]' => false,
'[accessible]' => [
'*' => true,
'id' => false
],
'[dirty]' => [],
'[original]' => [],
'[virtual]' => [],
'[hasErrors]' => false,
'[errors]' => [],
'[invalid]' => [],
'[repository]' => 'Articles'
}
$articleid = (int) 59777
$metaTitle = 'LATEST NEWS UPDATES | India’s vaccine policy needs clarity -K Sujatha Rao'
$metaKeywords = 'Covaxin,Covishield,Public goods,Public procurement,Vaccination,Vaccine policy,Universal Immunisation Programme'
$metaDesc = '-The Hindu
In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement
Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding...'
$disp = '<p style="text-align:justify">-The Hindu</p><p style="text-align:justify"><em>In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement</em></p><p style="text-align:justify">Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding of history, and present conditions. Considering the vast sea of unknowns surrounding COVID-19, it would be understandable to place a greater reliance on historical experience. Instead, India&rsquo;s vaccine policy appears to be one of experimentation. Despite several modifications, the final policy as articulated by the Prime Minister on June 7 continues to lack clarity in its intent, design, funding and outcomes. In seeking to pursue conflicting objectives, the policy architecture is complex, difficult to implement, and could be a nightmare for accountants.</p><p style="text-align:justify"><em>The vaccine policy</em></p><p style="text-align:justify">After much loss of time, the final policy has the following elements: the stated objective is universal access to free vaccinations in all government and accredited facilities; the design for achieving the objective is creating a dual market under which the Central government will procure 75% of the total quantity manufactured, leaving the residue for commercial sale. The funding will be a mix of public finance and out-of-pocket expenditure. The outcome is to ensure that all 95 crore adults are fully vaccinated by the end of this year.</p><p style="text-align:justify">The policy has two caveats related to pricing and volume of sales. While Covishield and Covaxin are supplied to the Central government at 150 per dose, the price for a consumer in the private market is capped at 780 for Covishield, 1,145 for Sputnik V and 1,410 for Covaxin. To avoid cornering of vaccines by corporates and enable medium and small hospitals to participate in vaccination, the Central government will specify hospital-wise and State-wise quotas for private sales. Based on the quota allocated, the said hospitals will procure the vaccine directly from the manufacturer or use the option of the National Health Authority portal, if accredited.</p><p style="text-align:justify">Compare this maze with the policy followed under the Universal Immunisation Programme &ndash; the Central government indicates the quantity required, the delivery schedules and the rates as per global tender, and supplies quality, ready-to-use vaccines to the States to be provided free. The manufacturer is left to dispose of excess quantity, if any, in accordance with market forces and without interference from the government. Under this system, the government has negotiated incredibly low prices due to the volume of its orders. In view of its wide reach, the private sector&rsquo;s participation, catering to the better-off sections which have the ability to pay, has averaged 5%-15% depending on the vaccine.</p><p style="text-align:justify">Please <a href="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true" title="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true">click here</a> to read more.&nbsp;</p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/india-s-vaccine-policy-needs-clarity-k-sujatha-rao.html"/>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
<link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
media="all"/>
<title>LATEST NEWS UPDATES | India’s vaccine policy needs clarity -K Sujatha Rao | Im4change.org</title>
<meta name="description" content="-The Hindu
In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement
Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding..."/>
<script src="https://im4change.in/js/jquery-1.10.2.js"></script>
<script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
<script language="javascript" type="text/javascript">
$(document).ready(function () {
var img = $("img")[0]; // Get my img elem
var pic_real_width, pic_real_height;
$("<img/>") // Make in memory copy of image to avoid css issues
.attr("src", $(img).attr("src"))
.load(function () {
pic_real_width = this.width; // Note: $(this).width() will not
pic_real_height = this.height; // work for in memory images.
});
});
</script>
<style type="text/css">
@media screen {
div.divFooter {
display: block;
}
}
@media print {
.printbutton {
display: none !important;
}
}
</style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
<tr>
<td class="top_bg">
<div class="divFooter">
<img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
</div>
</td>
</tr>
<tr>
<td id="topspace"> </td>
</tr>
<tr id="topspace">
<td> </td>
</tr>
<tr>
<td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
<form><input type="button" value=" Print this page "
onclick="window.print();return false;"/></form>
</td>
</tr>
<tr>
<td width="100%">
<h1 class="news_headlines" style="font-style:normal">
<strong>India’s vaccine policy needs clarity -K Sujatha Rao</strong></h1>
</td>
</tr>
<tr>
<td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
<p style="text-align:justify">-The Hindu</p><p style="text-align:justify"><em>In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement</em></p><p style="text-align:justify">Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding of history, and present conditions. Considering the vast sea of unknowns surrounding COVID-19, it would be understandable to place a greater reliance on historical experience. Instead, India’s vaccine policy appears to be one of experimentation. Despite several modifications, the final policy as articulated by the Prime Minister on June 7 continues to lack clarity in its intent, design, funding and outcomes. In seeking to pursue conflicting objectives, the policy architecture is complex, difficult to implement, and could be a nightmare for accountants.</p><p style="text-align:justify"><em>The vaccine policy</em></p><p style="text-align:justify">After much loss of time, the final policy has the following elements: the stated objective is universal access to free vaccinations in all government and accredited facilities; the design for achieving the objective is creating a dual market under which the Central government will procure 75% of the total quantity manufactured, leaving the residue for commercial sale. The funding will be a mix of public finance and out-of-pocket expenditure. The outcome is to ensure that all 95 crore adults are fully vaccinated by the end of this year.</p><p style="text-align:justify">The policy has two caveats related to pricing and volume of sales. While Covishield and Covaxin are supplied to the Central government at 150 per dose, the price for a consumer in the private market is capped at 780 for Covishield, 1,145 for Sputnik V and 1,410 for Covaxin. To avoid cornering of vaccines by corporates and enable medium and small hospitals to participate in vaccination, the Central government will specify hospital-wise and State-wise quotas for private sales. Based on the quota allocated, the said hospitals will procure the vaccine directly from the manufacturer or use the option of the National Health Authority portal, if accredited.</p><p style="text-align:justify">Compare this maze with the policy followed under the Universal Immunisation Programme – the Central government indicates the quantity required, the delivery schedules and the rates as per global tender, and supplies quality, ready-to-use vaccines to the States to be provided free. The manufacturer is left to dispose of excess quantity, if any, in accordance with market forces and without interference from the government. Under this system, the government has negotiated incredibly low prices due to the volume of its orders. In view of its wide reach, the private sector’s participation, catering to the better-off sections which have the ability to pay, has averaged 5%-15% depending on the vaccine.</p><p style="text-align:justify">Please <a href="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true" title="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true">click here</a> to read more. </p> </font>
</td>
</tr>
<tr>
<td> </td>
</tr>
<tr>
<td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
<form><input type="button" value=" Print this page "
onclick="window.print();return false;"/></form>
</td>
</tr>
</table></body>
</html>'
}
$cookies = []
$values = [
(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39
Notice (8): Undefined variable: urlPrefix [APP/Template/Layout/printlayout.ctp, line 8]
$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
'article_current' => object(App\Model\Entity\Article) {
'id' => (int) 59777,
'title' => 'India’s vaccine policy needs clarity -K Sujatha Rao',
'subheading' => null,
'description' => '<p style="text-align:justify">-The Hindu</p>
<p style="text-align:justify"><em>In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement</em></p>
<p style="text-align:justify">Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding of history, and present conditions. Considering the vast sea of unknowns surrounding COVID-19, it would be understandable to place a greater reliance on historical experience. Instead, India’s vaccine policy appears to be one of experimentation. Despite several modifications, the final policy as articulated by the Prime Minister on June 7 continues to lack clarity in its intent, design, funding and outcomes. In seeking to pursue conflicting objectives, the policy architecture is complex, difficult to implement, and could be a nightmare for accountants.</p>
<p style="text-align:justify"><em>The vaccine policy</em></p>
<p style="text-align:justify">After much loss of time, the final policy has the following elements: the stated objective is universal access to free vaccinations in all government and accredited facilities; the design for achieving the objective is creating a dual market under which the Central government will procure 75% of the total quantity manufactured, leaving the residue for commercial sale. The funding will be a mix of public finance and out-of-pocket expenditure. The outcome is to ensure that all 95 crore adults are fully vaccinated by the end of this year.</p>
<p style="text-align:justify">The policy has two caveats related to pricing and volume of sales. While Covishield and Covaxin are supplied to the Central government at ₹150 per dose, the price for a consumer in the private market is capped at ₹780 for Covishield, ₹1,145 for Sputnik V and ₹1,410 for Covaxin. To avoid cornering of vaccines by corporates and enable medium and small hospitals to participate in vaccination, the Central government will specify hospital-wise and State-wise quotas for private sales. Based on the quota allocated, the said hospitals will procure the vaccine directly from the manufacturer or use the option of the National Health Authority portal, if accredited.</p>
<p style="text-align:justify">Compare this maze with the policy followed under the Universal Immunisation Programme – the Central government indicates the quantity required, the delivery schedules and the rates as per global tender, and supplies quality, ready-to-use vaccines to the States to be provided free. The manufacturer is left to dispose of excess quantity, if any, in accordance with market forces and without interference from the government. Under this system, the government has negotiated incredibly low prices due to the volume of its orders. In view of its wide reach, the private sector’s participation, catering to the better-off sections which have the ability to pay, has averaged 5%-15% depending on the vaccine.</p>
<p style="text-align:justify">Please <a href="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true">click here</a> to read more. </p>
',
'credit_writer' => 'The Hindu, 22 June, 2021, https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true',
'article_img' => '',
'article_img_thumb' => '',
'status' => (int) 1,
'show_on_home' => (int) 1,
'lang' => 'EN',
'category_id' => (int) 16,
'tag_keyword' => '',
'seo_url' => 'india-s-vaccine-policy-needs-clarity-k-sujatha-rao',
'meta_title' => '',
'meta_keywords' => '',
'meta_description' => '',
'noindex' => (int) 1,
'publish_date' => object(Cake\I18n\FrozenDate) {},
'most_visit_section_id' => null,
'article_big_img' => null,
'liveid' => null,
'created' => object(Cake\I18n\FrozenTime) {},
'modified' => object(Cake\I18n\FrozenTime) {},
'edate' => '',
'tags' => [
[maximum depth reached]
],
'category' => object(App\Model\Entity\Category) {},
'[new]' => false,
'[accessible]' => [
[maximum depth reached]
],
'[dirty]' => [[maximum depth reached]],
'[original]' => [[maximum depth reached]],
'[virtual]' => [[maximum depth reached]],
'[hasErrors]' => false,
'[errors]' => [[maximum depth reached]],
'[invalid]' => [[maximum depth reached]],
'[repository]' => 'Articles'
},
'articleid' => (int) 59777,
'metaTitle' => 'LATEST NEWS UPDATES | India’s vaccine policy needs clarity -K Sujatha Rao',
'metaKeywords' => 'Covaxin,Covishield,Public goods,Public procurement,Vaccination,Vaccine policy,Universal Immunisation Programme',
'metaDesc' => '-The Hindu
In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement
Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding...',
'disp' => '<p style="text-align:justify">-The Hindu</p><p style="text-align:justify"><em>In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement</em></p><p style="text-align:justify">Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding of history, and present conditions. Considering the vast sea of unknowns surrounding COVID-19, it would be understandable to place a greater reliance on historical experience. Instead, India’s vaccine policy appears to be one of experimentation. Despite several modifications, the final policy as articulated by the Prime Minister on June 7 continues to lack clarity in its intent, design, funding and outcomes. In seeking to pursue conflicting objectives, the policy architecture is complex, difficult to implement, and could be a nightmare for accountants.</p><p style="text-align:justify"><em>The vaccine policy</em></p><p style="text-align:justify">After much loss of time, the final policy has the following elements: the stated objective is universal access to free vaccinations in all government and accredited facilities; the design for achieving the objective is creating a dual market under which the Central government will procure 75% of the total quantity manufactured, leaving the residue for commercial sale. The funding will be a mix of public finance and out-of-pocket expenditure. The outcome is to ensure that all 95 crore adults are fully vaccinated by the end of this year.</p><p style="text-align:justify">The policy has two caveats related to pricing and volume of sales. While Covishield and Covaxin are supplied to the Central government at 150 per dose, the price for a consumer in the private market is capped at 780 for Covishield, 1,145 for Sputnik V and 1,410 for Covaxin. To avoid cornering of vaccines by corporates and enable medium and small hospitals to participate in vaccination, the Central government will specify hospital-wise and State-wise quotas for private sales. Based on the quota allocated, the said hospitals will procure the vaccine directly from the manufacturer or use the option of the National Health Authority portal, if accredited.</p><p style="text-align:justify">Compare this maze with the policy followed under the Universal Immunisation Programme – the Central government indicates the quantity required, the delivery schedules and the rates as per global tender, and supplies quality, ready-to-use vaccines to the States to be provided free. The manufacturer is left to dispose of excess quantity, if any, in accordance with market forces and without interference from the government. Under this system, the government has negotiated incredibly low prices due to the volume of its orders. In view of its wide reach, the private sector’s participation, catering to the better-off sections which have the ability to pay, has averaged 5%-15% depending on the vaccine.</p><p style="text-align:justify">Please <a href="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true" title="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true">click here</a> to read more. </p>',
'lang' => 'English',
'SITE_URL' => 'https://im4change.in/',
'site_title' => 'im4change',
'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {
'id' => (int) 59777,
'title' => 'India’s vaccine policy needs clarity -K Sujatha Rao',
'subheading' => null,
'description' => '<p style="text-align:justify">-The Hindu</p>
<p style="text-align:justify"><em>In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement</em></p>
<p style="text-align:justify">Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding of history, and present conditions. Considering the vast sea of unknowns surrounding COVID-19, it would be understandable to place a greater reliance on historical experience. Instead, India’s vaccine policy appears to be one of experimentation. Despite several modifications, the final policy as articulated by the Prime Minister on June 7 continues to lack clarity in its intent, design, funding and outcomes. In seeking to pursue conflicting objectives, the policy architecture is complex, difficult to implement, and could be a nightmare for accountants.</p>
<p style="text-align:justify"><em>The vaccine policy</em></p>
<p style="text-align:justify">After much loss of time, the final policy has the following elements: the stated objective is universal access to free vaccinations in all government and accredited facilities; the design for achieving the objective is creating a dual market under which the Central government will procure 75% of the total quantity manufactured, leaving the residue for commercial sale. The funding will be a mix of public finance and out-of-pocket expenditure. The outcome is to ensure that all 95 crore adults are fully vaccinated by the end of this year.</p>
<p style="text-align:justify">The policy has two caveats related to pricing and volume of sales. While Covishield and Covaxin are supplied to the Central government at ₹150 per dose, the price for a consumer in the private market is capped at ₹780 for Covishield, ₹1,145 for Sputnik V and ₹1,410 for Covaxin. To avoid cornering of vaccines by corporates and enable medium and small hospitals to participate in vaccination, the Central government will specify hospital-wise and State-wise quotas for private sales. Based on the quota allocated, the said hospitals will procure the vaccine directly from the manufacturer or use the option of the National Health Authority portal, if accredited.</p>
<p style="text-align:justify">Compare this maze with the policy followed under the Universal Immunisation Programme – the Central government indicates the quantity required, the delivery schedules and the rates as per global tender, and supplies quality, ready-to-use vaccines to the States to be provided free. The manufacturer is left to dispose of excess quantity, if any, in accordance with market forces and without interference from the government. Under this system, the government has negotiated incredibly low prices due to the volume of its orders. In view of its wide reach, the private sector’s participation, catering to the better-off sections which have the ability to pay, has averaged 5%-15% depending on the vaccine.</p>
<p style="text-align:justify">Please <a href="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true">click here</a> to read more. </p>
',
'credit_writer' => 'The Hindu, 22 June, 2021, https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true',
'article_img' => '',
'article_img_thumb' => '',
'status' => (int) 1,
'show_on_home' => (int) 1,
'lang' => 'EN',
'category_id' => (int) 16,
'tag_keyword' => '',
'seo_url' => 'india-s-vaccine-policy-needs-clarity-k-sujatha-rao',
'meta_title' => '',
'meta_keywords' => '',
'meta_description' => '',
'noindex' => (int) 1,
'publish_date' => object(Cake\I18n\FrozenDate) {},
'most_visit_section_id' => null,
'article_big_img' => null,
'liveid' => null,
'created' => object(Cake\I18n\FrozenTime) {},
'modified' => object(Cake\I18n\FrozenTime) {},
'edate' => '',
'tags' => [
(int) 0 => object(Cake\ORM\Entity) {},
(int) 1 => object(Cake\ORM\Entity) {},
(int) 2 => object(Cake\ORM\Entity) {},
(int) 3 => object(Cake\ORM\Entity) {},
(int) 4 => object(Cake\ORM\Entity) {},
(int) 5 => object(Cake\ORM\Entity) {},
(int) 6 => object(Cake\ORM\Entity) {}
],
'category' => object(App\Model\Entity\Category) {},
'[new]' => false,
'[accessible]' => [
'*' => true,
'id' => false
],
'[dirty]' => [],
'[original]' => [],
'[virtual]' => [],
'[hasErrors]' => false,
'[errors]' => [],
'[invalid]' => [],
'[repository]' => 'Articles'
}
$articleid = (int) 59777
$metaTitle = 'LATEST NEWS UPDATES | India’s vaccine policy needs clarity -K Sujatha Rao'
$metaKeywords = 'Covaxin,Covishield,Public goods,Public procurement,Vaccination,Vaccine policy,Universal Immunisation Programme'
$metaDesc = '-The Hindu
In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement
Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding...'
$disp = '<p style="text-align:justify">-The Hindu</p><p style="text-align:justify"><em>In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement</em></p><p style="text-align:justify">Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding of history, and present conditions. Considering the vast sea of unknowns surrounding COVID-19, it would be understandable to place a greater reliance on historical experience. Instead, India’s vaccine policy appears to be one of experimentation. Despite several modifications, the final policy as articulated by the Prime Minister on June 7 continues to lack clarity in its intent, design, funding and outcomes. In seeking to pursue conflicting objectives, the policy architecture is complex, difficult to implement, and could be a nightmare for accountants.</p><p style="text-align:justify"><em>The vaccine policy</em></p><p style="text-align:justify">After much loss of time, the final policy has the following elements: the stated objective is universal access to free vaccinations in all government and accredited facilities; the design for achieving the objective is creating a dual market under which the Central government will procure 75% of the total quantity manufactured, leaving the residue for commercial sale. The funding will be a mix of public finance and out-of-pocket expenditure. The outcome is to ensure that all 95 crore adults are fully vaccinated by the end of this year.</p><p style="text-align:justify">The policy has two caveats related to pricing and volume of sales. While Covishield and Covaxin are supplied to the Central government at 150 per dose, the price for a consumer in the private market is capped at 780 for Covishield, 1,145 for Sputnik V and 1,410 for Covaxin. To avoid cornering of vaccines by corporates and enable medium and small hospitals to participate in vaccination, the Central government will specify hospital-wise and State-wise quotas for private sales. Based on the quota allocated, the said hospitals will procure the vaccine directly from the manufacturer or use the option of the National Health Authority portal, if accredited.</p><p style="text-align:justify">Compare this maze with the policy followed under the Universal Immunisation Programme – the Central government indicates the quantity required, the delivery schedules and the rates as per global tender, and supplies quality, ready-to-use vaccines to the States to be provided free. The manufacturer is left to dispose of excess quantity, if any, in accordance with market forces and without interference from the government. Under this system, the government has negotiated incredibly low prices due to the volume of its orders. In view of its wide reach, the private sector’s participation, catering to the better-off sections which have the ability to pay, has averaged 5%-15% depending on the vaccine.</p><p style="text-align:justify">Please <a href="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true" title="https://www.thehindu.com/opinion/op-ed/indias-vaccine-policy-needs-clarity/article34894911.ece?homepage=true">click here</a> to read more. </p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'
include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement
Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding of history, and present conditions. Considering the vast sea of unknowns surrounding COVID-19, it would be understandable to place a greater reliance on historical experience. Instead, India’s vaccine policy appears to be one of experimentation. Despite several modifications, the final policy as articulated by the Prime Minister on June 7 continues to lack clarity in its intent, design, funding and outcomes. In seeking to pursue conflicting objectives, the policy architecture is complex, difficult to implement, and could be a nightmare for accountants.
The vaccine policy
After much loss of time, the final policy has the following elements: the stated objective is universal access to free vaccinations in all government and accredited facilities; the design for achieving the objective is creating a dual market under which the Central government will procure 75% of the total quantity manufactured, leaving the residue for commercial sale. The funding will be a mix of public finance and out-of-pocket expenditure. The outcome is to ensure that all 95 crore adults are fully vaccinated by the end of this year.
The policy has two caveats related to pricing and volume of sales. While Covishield and Covaxin are supplied to the Central government at 150 per dose, the price for a consumer in the private market is capped at 780 for Covishield, 1,145 for Sputnik V and 1,410 for Covaxin. To avoid cornering of vaccines by corporates and enable medium and small hospitals to participate in vaccination, the Central government will specify hospital-wise and State-wise quotas for private sales. Based on the quota allocated, the said hospitals will procure the vaccine directly from the manufacturer or use the option of the National Health Authority portal, if accredited.
Compare this maze with the policy followed under the Universal Immunisation Programme – the Central government indicates the quantity required, the delivery schedules and the rates as per global tender, and supplies quality, ready-to-use vaccines to the States to be provided free. The manufacturer is left to dispose of excess quantity, if any, in accordance with market forces and without interference from the government. Under this system, the government has negotiated incredibly low prices due to the volume of its orders. In view of its wide reach, the private sector’s participation, catering to the better-off sections which have the ability to pay, has averaged 5%-15% depending on the vaccine.
